Aurobindo Pharma Subsidiary Secures European Commission Approval
CuraTeQ Biologics, the wholly owned step-down subsidiary of Aurobindo Pharma Ltd, on 2 July announced that it has obtained marketing authorisation from the European Commission...
Tag : CuraTeQ Biologics
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine
Pharmaceutical major Aurobindo Pharma Ltd, on 10 April, announced that its subsidiary, CuraTeQ Biologics, has successfully completed the phase 1 Trial of its new bone...
Aurobindo Pharma Arm Enters into an Agreement with US Company; Shares Prices Fell
Aurobindo Pharma’s share price plunged and turned red on July 10 after its wholly-owned subsidiary CuraTeQ Biologics announced that it has entered into an exclusive...